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Introduction 
Coagulase negative staphylococci (CoNS) are 
commensals of non-sterile sites in humans and become 
pathogenic mostly when the host is 
immunocompromised by prior diseases or invasive 
surgical or related procedures [1]. Slime or biofilm 
production by CoNS has been identified as an 
important factor in the pathogenesis of infections as 
bacteria organized in biofilms are protected from the 
action of antibiotics and the immune system [2]. 
Biofilm is ascribed the most important virulence factor 
of S. epidermidis as it enables attachment and 
persistence of the bacteria on foreign materials [3,4]. 
Other studies have indicated a correlation between 
antibiotic resistance and slime expression. For 
instance, insertion of a certain transposon influences 
both biofilm formation and the expression of 
methicillin resistance in S. epidermidis [4]. In another 
study methicillin resistance was found to be 
significantly higher in slime positive isolates (81%) 
than in slime negative isolates (57%) [5]. Due to the 
frequent recovery of CoNS in clinical infections their 
antibiotic susceptibility profile as well as their biofilm 
forming ability was investigated in this study. 
 
The Study 
One hundred clinical strains of CoNS comprising 
S. cohnii (n = 7), S. cohnii ssp. urealyticus (n = 12), S. 
epidermidis (n = 5), S. haemolyticus (n = 20), S. 
hominis (n = 26), S. intermedius (n = 4), S. klosii ( n= 
4), S. lugdunensis (n = 4), S. saprophyticus (n = 7), S. 
sciuri (n = 5), S. warneri (n = 3) and S. xylosus (n = 3) 
were isolated from various clinical specimens obtained 
from wards and outpatient departments of 8 medical 
centres from the states of Lagos and Ogun in Nigeria. 
The isolates were identified by cultural and 
biochemical characteristics. Identification to species 
level was performed with the VITEK-2 automated 
system (bioMérieux, Marcy l'Etoile, France). 
Susceptibility to 19 different antimicrobial agents 
(benzylpenicillin, oxacillin [methicillin], gentamicin, 
tobramycin, levofloxacin, moxifloxacin, erythromycin, 
clindamycin, linezolid, teicoplanin, vancomycin, 
tetracycline, tigecycline, fosfomycin, nitrofurantoin, 
fusidic acid, mupirocin, rifampicin and trimethoprim-
sulfamethoxazole) was tested with the VITEK-2 
automated system. The biofilm- forming capacity of 
one S. lugdunensis strain and five S. epidermidis 
strains obtained in this study was investigated by a 
method previously described [6].  
Antibiotic resistance by the CoNS was highest 
against tetracycline (74.7%) followed by penicillin 
(69.5%) and fosfomycin (68.4%). Mupirocin and 
nitrofurantoin produced the highest in vitro activities 
against the CoNS. Staphylococcus intermedius and S. 
xylosus exhibited extreme resistance to most of the 
antibiotics tested. Resistance to methicillin was 41% 
(Table 1). The ratio of methicillin susceptible (MS) 
CoNS to methicillin resistant (MR) CoNS was 
approximately 2:1 (59% to 41%). High level resistance 
to methicillin was evident in S. intermedius (100%), S. 
xylosus (100%) S. haemolyticus (95%) and S. 
epidermidis (60%).  
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  Table 1. Antimicrobial resistance profile of coagulase negative staphylococcal strains 




























P 42.9 75 100 100 23.1 100 75 0 100 100 100 100 
OX 28.6 25 60 95 11.5 100 0 0 42.8 0 33.3 100 
GM 0 0 40 30 7.7 100 0 0 0 20 0 33.3 
TM 0 0 40 25 7.7 100 0 0 0 20 0 100 
LEV 0 0 40 70 7.7 100 0 0 0 20 33.3 33.3 
MXF 0 0 0 25 0 100 0 0 0 20 33.3 100 
E 0 16.7 40 20 7.7 100 75 0 0 0 33.3 100 
CN 0 18.3 40 20 3.8 100 25 0 0 80 33.3 100 
LNZ 0 0 0 0 0 100 0 0 0 0 0 100 
TEC 0 0 0 0 0 100 0 0 0 0 0 100 
VAN 0 0 0 0 0 100 0 0 0 0 0 100 
TE 57.1 58.3 100 85 80.8 100 24 100 71.4 60 66.7 100 
TGC 0 0 0 0 0 100 0 0 0 0 0 0 
FOS 71.4 25 0 85 88.5 100 100 100 71.4 0 100 0 
NIT 0 0 0 0 0 50 0 0 0 0 0 0 
FA 100 91.7 0 10 11.5 100 75 0 100 100 33.3 100 
MUP 0 0 0 0 0 0 0 0 0 0 0 0 
RIF 0 0 0 10 3.8 100 0 0 14.2 0 0 100 
SXT 0 0 40 90 15.4 100 25 0 57.1 0 33.3 100 
*Values represent percentages 
P: benzylpenicillin; OX:  oxacillin; GM: gentamicin; TM: tobramycin; LEV: levofloxacin; MXF: moxifloxacin; E: erythromycin; CN: clindamycin; LNZ: 
linezolid; TEC: teicoplanin; VAN: vancomycin; TE: tetracycline; TGC: tigecycline; FOS: fosfomycin; NIT: nitrofurantoin; FA: fusidic acid; MUP: 
mupirocin; RIF: rifampcin; SXT: trimethoprim-sulfamethoxazole. 
Figure 1. Antimicrobial resistance patterns of MRCoNS and MSCoNS 
P: benzylpenicillin; OX: oxacillin; GM: gentamicin; TM: tobramycin; LEV: 
levofloxacin; MXF: moxifloxacin; E: erythromycin; CN: clindamycin; LNZ: 
linezolid; TEC: teicoplanin; VAN: vancomycin; TE: tetracycline; TGC: tigecycline; 
FOS: fosfomycin; NIT: nitrofurantoin; FA: fusidic acid; MUP: mupirocin; RIF: 
Rifampicin; SXT: trimethoprim-sulfamethoxazole 
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A comparison of the antibiotic susceptibilities of (MS) 
CoNS and (MR) CoNS showed that MR CoNS were 
more resistant (Figure 1). Biofilm formation was 
observed in three of the S. epidermidis strains tested. 
The S. lugdunensis strain did not form biofilm.  
The results of the antibiotic susceptibility test 
showed that the β-lactam antibiotics were less 
effective, particularly the penicillins against CoNS. 
The emergence of large clusters of methicillin resistant 
CoNS in this study portend further therapeutic 
dilemma. These strains have been shown to spread 
within and between hospitals [7,8]. The 41% of CoNS 
which were methicillin resistant in this present study is 
encouragingly lower than the proportion (60-70%) 
seen in some hospitals in Europe [9]. Mupirocin’s 
excellent activity against the CoNS is important as it 
will continue to be the drug of choice for 
decontaminating the nasal cavity of carriers of 
staphylococci [10].  
The resistance pattern in S. intermedius and S. 
xylosus as seen in this present study is of major 
concern. Of particular interest is the 100% resistance 
of these two species to antibiotics (methicillin, 
linezolid, teicoplanin, vancomycin, tigecycline with 
the exception of mupirocin) that produced 100% 
activity against other species. The present study 
showed that organisms that lacked the ability to form 
biofilms were more susceptible to antibiotics. It is 
important to observe also that two of the five strains of 
S. epidermidis that failed to form biofilms represented 
the antibiotic sensitive clone. Our finding supports an 
earlier work that methicillin resistance in CoNS was 
higher in species that produce slime [5]. It is 
worthwhile to note that several of the isolates in this 
study could be contaminants and not real pathogens. 
In conclusion, further studies are required to 
determine the epidemiological implication of 
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